deltatrials
Unknown PHASE3 NCT01702103

Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays

MULTICENTER, RANDOMIZED, DOUBLE BLIND, CONTROLLED, CLINICAL STUDY TO DEMONSTRATE THE THERAPEUTIC CLINICAL EQUIVALENCE OF TWO MOMETASONE NASAL SPRAYS IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS.

Sponsor: PH&T S.p.A.

Conditions Itching Nasal Obstruction Sneezing
Interventions Mometasone furoate
Updated 5 times since 2017 Last updated: Oct 4, 2012 Started: Oct 31, 2012 Primary completion: Jan 31, 2013 Completion: Mar 31, 2013

Listed as NCT01702103, this PHASE3 trial focuses on Itching and Nasal Obstruction and remains ongoing. Sponsored by PH&T S.p.A., it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • PH&T S.p.A.
Data source: PH&T S.p.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Buenos Aires, Argentina